Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY3P3 (RNA, Ro-associated Y3 pseudogene 3) is a pseudogene of the RNY3 gene, which itself encodes a non-coding Y RNA. Pseudogenes like RNY3P3 are typically non-functional genomic DNA sequences related to functional genes; they generally do not produce functional transcripts or proteins. There is no current evidence that RNY3P3 is a functional therapeutic target or has direct roles in molecular signaling, disease, or as a biomarker. It is not a receptor, enzyme, transporter, or other common drug target class. Functional studies and disease associations reference the RNY3 gene, not its pseudogene RNY3P3. RNY3P3 is a pseudogene, not to be confused with the functional RNY3 gene. There is strong evidence RNY3P3 does not represent a direct biological or therapeutic target, and no disease, functional, or molecular mechanism information specifically for the pseudogene is available in scientific databases or literature. If seeking information on biology, function, or therapeutic relevance, use the parental gene RNY3 (RNA, Ro60-associated Y3), not RNY3P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y3 pseudogene 3 (RNY3P3).